Jesús, S.
Labrador-Espinosa, M. A.
Adarmes, A. D.
Méndel-Del Barrio, C.
Martínez-Castrillo, J. C.
Alonso-Cánovas, A.
Sánchez Alonso, P.
Novo-Ponte, S.
Alonso-Losada, M. G.
López Ariztegui, N.
Segundo Rodríguez, J. C.
Morales, M. I.
Gastón, I.
Lacruz Bescos, F.
Clavero Ibarra, P.
Kulisevsky, J.
Pagonabarraga, J.
Pascual-Sedano, B.
Martínez-Martín, P.
Santos-García, D.
Mir, P.
,
Aguilar, M.
Almeria, M.
Álvarez Sauco, M.
Arnáiz, S.
Arribas, S.
Ascunce Vidondo, A.
Bernardo, N.
Bejr-Kasem, H.
Blázquez Estrada, M.
Botí, M.
Borrue, C.
Cabello González, C.
Cámara Lorenzo, A.
Carrillo, F.
Carrillo Padilla, F.
Casas, E.
Catalán, M. J.
Cortina Fernández, A.
Cots Foraster, A.
Crespo Cuevas, A.
Cubo, E.
Díez-Fairen, M.
Escalante, S.
Erro, E.
de Fábregues-Boixar, O.
Fernández Guillán, N.
Gámez, P.
Gallego, M.
García Caldentey, J.
García Campos, C.
García Moreno, J. M.
Gómez Garre, M. P.
González Aloy, J.
González Ardura, J.
González García, B.
González Palmás, M. J.
González Toledo, G. R.
Golpe Díaz, A.
Grau Solá, M.
Guardia, G.
Horta-Barba, A.
Infante, J.
Kurtis, M.
Hernández Vara, J.
Labandeira, C.
Lage Castro, M.
Legarda, I.
López Díaz, L. M.
López Manzanares, L.
López Seoane, B.
Macías, Y.
Mata, M.
Martí Andres, G.
Martí, M. J.
McAfee, D.
Meitín, M. T.
Menéndez González, M.
Miranda Santiago, J.
Moreno Diéguez, A.
Nogueira, V.
Novo Amado, A.
Ordás, C.
Pastor, P.
Paz González, J. M.
Pareés, I.
Pérez Fuertes, A.
Pérez Noguera, R.
Planellas, L.
Prats, M. A.
Prieto Jurczynska, C.
Pueyo, M.
Puente, V.
Redondo Rafales, N.
Rodríguez Méndez, L.
Rodríguez Pérez, A. B.
Roldán, F.
De Arcos, M. Ruíz
Ruíz Martínez, J.
Sánchez-Carpintero, M.
Sánchez Díez, G.
Sánchez Rodríguez, A.
Santacruz, P.
Seijo, M.
Serarols, A.
Sierra Peña, M.
Solano, B.
Suárez-Castro, E.
Tartari, J. P.
Valero, C.
Vargas, L.
Vázquez Gómez, R.
Vela, L.
Villanueva, C.
Vives, B.
Villar, M. D.
Funding for this research was provided by:
www.curemoselparkinson.org
Article History
Received: 7 January 2020
Accepted: 14 August 2020
First Online: 9 October 2020
Competing interests
: S. Jesús has received honoraria from Abbvie, Bial, Merz, UCB, Italfarmaco and Zambon. She holds the competitive contract "Juan Rodés" supported by the Instituto de Salud Carlos III (JR16/00031). She received grants from the Spanish Ministry of Economy and Competitiveness (PI18/01898) and the Consejería de Salud de la Junta de Andalucía (PI-0459-2018). M. A. Labrador-Espinosa: None. A. D. Adarmes has received honoraria from Abbvie and Italfarmaco. C. Méndez del Barrio has received honoraria from Neuraxpharm. J. C. Martínez-Castrillo has received grants/research support from Allergan, Abbvie, Bial, Ipsen, Italfarmaco, Merz, and Zambon; honoraria or consultation fees from Allergan, AbbVie, Bial, Exeltis, Ipsen, Italfarmaco, Merz, Ipsen, Orion, UCB, and Zambon; and company sponsored speaker’s bureau from Allergan, Abbvie, Bial, Krka, Ipsen, Italfarmaco, Merz, UCB, and Zambon. A. Alonso-Cánovas has received honoraria as lecturer in seminars, simposia and teaching courses, scientific advisory, and travel and congress attendance sponsor with Zambon and Abbvie. P. Sánchez Alonso has received honoraria as lecturer in seminars, symposia and teaching courses, scientific advisory, and travel and congress attendance sponsor with Zambon, Abbvie, Bial. S. Novo-Ponte has received unrestricted educational support from Abbvie, Zambon, Novartis. M. G. Alonso-Losada has received honoraria for educational presentations and advice service by Zambon and Bial. N. López Ariztegui has received honoraria for educational presentations and/or advice service by Abbvie, UCB Pharma, Italfarmaco, Zambon, Bial, and Teva. J. CSegundo Rodríguez: None. M. I. Morales: None. I. Gastón has received research support from Abbvie and Zambon and has served as a consultant for Abbvie, Exelts and Zambon. F. Lacruz Bescos: None. P. Clavero Ibarra: None. J. Kulisevsky has received consulting and lecture fees from Roche, Zambon, Teva and Bial. He got research funding fromRoche, Zambon, Ciberned, Instituto de Salud Carlos III and FundacióLa Maratóde TV3. J. Pagonabarraga has served on advisory or speakers' boards, and received honoraria from UCB, Zambon, AbbVie, Italfarmaco, Allergan, Ipsen and Bial, and received grants from CIBERNED and FIS PI14/02058) (Spanish Government grants) and Fundació La Marató de TV3 20142910. B. Pascual-Sedano has received honoraria by Abbvie and UCB Pharma. P. Martinez-Martin Honoraria: from Editorial Viguera for lecturing in courses; International Parkinson and Movement Disorder Society (IPMDS) for management of the Program on Rating Scales; Air Liquide, Abbvie, and HM Hospitales de Madrid for advice in clinic-epidemiological studies. License fee payments for the King's Parkinson's Disease Pain scale. IPMDS grants for attendance to the IPMDS Congress (2018) and for development and validation of the MDS-NMS. D. Santos-García has received honoraria for educational presentations and/or advice service by Abbvie, UCB Pharma, Lundbeck, KRKA, Zambon, Bial, and Teva. P. Mir has received honoraria from AbbVie, Abbott, Allergan, Bial, Merz, UCB, and Zambon. He has received grants from the Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación). He also received grants from Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526, CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, and the Fundación Mutua Madrileña.